32. Prevention: Clinical 913-08

913-08 - EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: PRIMARY RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (BEIJERINCK)

Session
913 - Highlighted Original Research: Prevention and the Year in Review
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
913-08
Presentation Rating
 |